- Home
- SPRB
as 11-14-2024 1:36pm EST
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 22.8M | IPO Year: | 2020 |
| Target Price: | $2.50 | AVG Volume (30 days): | 400.8K |
| Analyst Decision: | Hold | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.96 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.41 - $5.95 | Next Earning Date: | 11-11-2024 |
| Revenue: | $7,101,000 | Revenue Growth: | -1.40% |
| Revenue Growth (this year): | -37.13% | Revenue Growth (next year): | -72.13% |
Latest Spruce Biosciences Inc. News
SPRB Breaking Stock News: Dive into SPRB Ticker-Specific Updates for Smart Investing
Simply Wall St.
16 hours ago
Spruce Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
TipRanks
2 days ago
Spruce Biosciences Reports Q3 2024 Earnings and Updates
Zacks
4 days ago
Spruce Biosciences, Inc. (SPRB) Reports Q3 Loss, Lags Revenue Estimates
Business Wire
4 days ago
Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Business Wire
17 days ago
Spruce Biosciences to Participate in the Guggenheim Securities Healthcare Innovation Conference
Business Wire
2 months ago
Spruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Zacks
3 months ago
Spruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates
Business Wire
3 months ago
Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
Compare SPRB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SPRB Spruce Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.